Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;34(5):431-447.
doi: 10.1007/s10552-022-01657-9. Epub 2023 Feb 15.

mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study

Affiliations

mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study

Mmadili N Ilozumba et al. Cancer Causes Control. 2023 May.

Abstract

Background: Obesity is known to stimulate the mammalian target of rapamycin (mTOR) signaling pathway and both obesity and the mTOR signaling pathway are implicated in breast carcinogenesis. We investigated potential gene-environment interactions between mTOR pathway genes and obesity in relation to breast cancer risk among Black women.

Methods: The study included 1,655 Black women (821 incident breast cancer cases and 834 controls) from the Women's Circle of Health Study (WCHS). Obesity measures including body mass index (BMI); central obesity i.e., waist circumference (WC) and waist/hip ratio (WHR); and body fat distribution (fat mass, fat mass index and percent body fat) were obtained by trained research staff. We examined the associations of 43 candidate single-nucleotide polymorphisms (SNPs) in 20 mTOR pathway genes with breast cancer risk using multivariable logistic regression. We next examined interactions between these SNPs and measures of obesity using Wald test with 2-way interaction term.

Results: The variant allele of BRAF (rs114729114 C > T) was associated with an increase in overall breast cancer risk [odds ratio (OR) = 1.81, 95% confidence interval (CI) 1.10-2.99, for each copy of the T allele] and the risk of estrogen receptor (ER)-defined subtypes (ER+ tumors: OR = 1.83, 95% CI 1.04,3.29, for each copy of the T allele; ER- tumors OR = 2.14, 95% CI 1.03,4.45, for each copy of the T allele). Genetic variants in AKT, AKT1, PGF, PRKAG2, RAPTOR, TSC2 showed suggestive associations with overall breast cancer risk and the risk of, ER+ and ER- tumors (range of p-values = 0.040-0.097). We also found interactions of several of the SNPs with BMI, WHR, WC, fat mass, fat mass index and percent body fat in relation to breast cancer risk. These associations and interactions, however, became nonsignificant after correction for multiple testing (FDR-adjusted p-value > 0.05).

Conclusion: We found associations between mTOR genetic variants and breast cancer risk as well as gene and body fatness interactions in relation to breast cancer risk. However, these associations and interactions became nonsignificant after correction for multiple testing. Future studies with larger sample sizes are required to confirm and validate these findings.

Keywords: Black women; Breast cancer; Effect modification; Obesity; mTOR pathway.

PubMed Disclaimer

Conflict of interest statement

Statements and Declaration

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Figures

Figure 1:
Figure 1:
Putative mechanisms of how obesity, physical inactivity and excessive energy intake promote different kinds of pathways that lead to cell proliferation and inhibition of apoptosis in breast tissue

Similar articles

Cited by

References

    1. Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013;2013(697521):1–25. - PMC - PubMed
    1. Simpson ER, Brown KA. Obesity and breast cancer: Role of inflammation and aromatase. J Mol Endocrinol. 2013;51(3). - PubMed
    1. Simone V, D’Avenia M, Argentiero A, Felici C, Rizzo FM, Pergola G De, et al. Obesity and breast cancer: Molecular interconnections and potential clinical applications. Oncologist. 2016;21:404–17. - PMC - PubMed
    1. Macciò A, Madeddu C. Obesity, inflammation, and postmenopausal breast cancer: Therapeutic implications. ScientificWorldJournal. 2011;11:2020–36. - PMC - PubMed
    1. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: New insights into breast cancer development and progression. Am Soc Clin Oncol Educ B. 2013;33:46–51. - PMC - PubMed

MeSH terms